Myeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation

American Journal of Transplantation · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles